Internal Medicine, Cardiovascular Disease · Brooklyn, NY
NPI
1669430633
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
4802 10th Ave
Brooklyn, NY, 11219
Phone (718) 283-7147
Groups this clinician bills Medicare through
Medicare paid, 2024
$117K
3,163 services
Medicare patients, 2024
1,664
Average age 78
Drug cost, 2024
$4.2M
1,122 prescriptions
Company payments, 2025
$147K
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ronald Wharton was code 93306 (echocardiography (tte/tee)), 1,046 times for 957 patients. In total Ronald Wharton billed 3,163 services in 31 codes, and Medicare paid $117K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-08-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93306 Echocardiography (TTE/TEE) | Facility | 1,046 | 957 | $57.13 | $60K |
| 93010 Electrocardiogram | Facility | 616 | 511 | $7.12 | $4,387 |
| 93308 Echocardiography (TTE/TEE) | Facility | 272 | 197 | $21.19 | $5,764 |
| 93325 Echocardiography (TTE/TEE) | Facility | 211 | 184 | $2.61 | $551 |
| 93356 Echocardiography (TTE/TEE) | Facility | 179 | 174 | $10.10 | $1,808 |
| 93321 Echocardiography (TTE/TEE) | Facility | 169 | 128 | $6.09 | $1,030 |
| 93000 Electrocardiogram | Office | 142 | 90 | $12.83 | $1,822 |
| 93312 Echocardiography (TTE/TEE) | Facility | 103 | 102 | $90.71 | $9,344 |
| 93320 Echocardiography (TTE/TEE) | Facility | 100 | 99 | $15.22 | $1,522 |
| 99215 Office E&M - Established | Office | 77 | 51 | $162.16 | $12K |
| 76376 CT Scan | Facility | 74 | 62 | $8.09 | $599 |
| 99214 Office E&M - Established | Office | 34 | 30 | $100.43 | $3,415 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 22 | 19 | $14.90 | $328 |
| 99205 Office E&M - New | Office | 19 | 19 | $195.81 | $3,720 |
| 93355 Echocardiography (TTE/TEE) | Facility | 17 | 17 | $199.50 | $3,392 |
By year: 2022 $91K for 2,048 services; 2023 $106K for 2,629 services; 2024 $117K for 3,163 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ronald Wharton prescribed most often to Medicare patients was Camzyos (Mavacamten), with 521 prescriptions and refills. In total Ronald Wharton wrote 1,122 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Camzyos Mavacamten | 521 | 527 | 57 | $4.1M |
| Metoprolol Succinate Generic | 82 | 237 | 33 | $1,621 |
| Amlodipine Besylate Generic | 77 | 223 | 28 | $540 |
| Atorvastatin Calcium Generic | 42 | 126 | 16 | $460 |
| Entresto Sacubitril/Valsartan | 36 | 65 | 12 | $42K |
| Eliquis Apixaban | 33 | 57 | 12 | $32K |
| Furosemide Generic | 31 | 55 | 14 | $153 |
| Valsartan Generic | 30 | 84 | 13 | $640 |
| Farxiga Dapagliflozin Propanediol | 26 | 54 | Under 11 | $29K |
| Rosuvastatin Calcium Generic | 19 | 51 | Under 11 | $149 |
| Losartan Potassium Generic | 16 | 48 | Under 11 | $58.86 |
| Nebivolol Hcl Generic | 15 | 31 | Under 11 | $249 |
| Praluent Pen Alirocumab | 13 | 13 | Under 11 | $6,220 |
| Jardiance Empagliflozin | 13 | 37 | Under 11 | $21K |
| Lansoprazole Generic | 12 | 32 | Under 11 | $359 |
Brand drugs: 696 claims; generic drugs: 426 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ronald Wharton $147K ($147K in general payments such as food, travel and fees) from 4 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $106K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.